Ashion Analytics receives Medicare coverage for GEM ExTra® assay for cancer patients
PHOENIX, Ariz. — July 14, 2020 — Ashion Analytics LLC announced today that Palmetto GBA, a Medicare administrative contractor for the Molecular Diagnostic Services Program (MolDX), has awarded coverage to its proprietary cancer profiling test, GEM ExTra®, one of the nation’s most comprehensive genomic cancer analysis tests. GEM ExTra, Ashion’s flagship clinical assay, detects tumor-specific…